PDCD1 and cancer: These transcription regulation mechanisms define PD-1 expression’s upregulation and T cell function under physiological and pathological conditions, and provide the basis for the development of immune checkpoint inhibitor immunotherapy for human diseases such as cancer [1,11,33].